Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline

NCT00901823 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Did not support the planned development of DCCR in the new indication

Conditions

Hypertriglyceridemia

Interventions

DRUG: Diazoxide choline
DRUG: Diazoxide choline high dose

Sponsor

Essentialis, Inc.